EMMA insider filings

Emmaus Life Sciences, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-02. Screen EMMA transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
LEE WILLIS C — CEO, Director16 legs · 530,767 sh · $18,126——

Recent insider filings — Emmaus Life Sciences, Inc.

FiledFormInsiderReported transactionsSource
2026-09-024LEE WILLIS C — CEO, DirectorPurchase (P): 70,000 @ $0.02 · Purchase (P): 170,000 @ $0.01 · Purchase (P): 46,000 @ $0.04 · Purchase (P): 50,000 @ $0.05 · Purchase (P): 94,767 @ $0.06 · Purchase (P): 100,000 @ $0.05EDGAR
2024-09-184Lim Seah H. — DirectorPurchase (P): 20,000 @ $0.04EDGAR
2024-02-294LEE WILLIS C — Co-President & COO, DirectorPurchase (P): 13,200 @ $0.12 · Purchase (P): 10,000 @ $0.13 · Purchase (P): 15,000 @ $0.12 · Purchase (P): 77,000 @ $0.13EDGAR
2024-02-054Lim Seah H. — DirectorGrant/award (A): 100,000 (derivative) @ $0.15EDGAR
2024-02-054Stark Charles William — CSO & EVP Clinical DevelopmentGrant/award (A): 200,000 (derivative) @ $0.15EDGAR
2024-02-054Sekulich George — Co-President & CCO, DirectorGrant/award (A): 200,000 (derivative) @ $0.15EDGAR
2024-02-054ZEN Wei Peu — DirectorGrant/award (A): 100,000 (derivative) @ $0.15EDGAR
2024-02-054Zwicker Ian Harvey — DirectorGrant/award (A): 100,000 (derivative) @ $0.15EDGAR
2024-02-054NAGASAKI YASUSHI — CFOGrant/award (A): 200,000 (derivative) @ $0.15EDGAR
2024-02-054LEE WILLIS C — Co-President & COO, DirectorGrant/award (A): 200,000 (derivative) @ $0.15EDGAR
2024-01-034/ALEE WILLIS C — COO, DirectorPurchase (P): 6,500 @ $0.21 · Purchase (P): 6,000 @ $0.15 · Purchase (P): 1,100 @ $0.12 · Purchase (P): 12,000 @ $0.12 · Purchase (P): 36,000 @ $0.12 · Purchase (P): 59,400 @ $0.12EDGAR
2023-12-214Lim Seah H. — DirectorSale (S): 32,500 @ $0.05EDGAR
2023-12-194Lim Seah H. — DirectorPurchase (P): 25,400 @ $0.11 · Purchase (P): 92,100 @ $0.27 · Purchase (P): 20,000 @ $0.15 · Purchase (P): 1,700 @ $0.15 · Sale (S): 6,000 @ $0.11 · Other (J): 4,447,426 @ $0.29 · +1 moreEDGAR
2023-12-194ZEN Wei Peu — DirectorOther (J): 3,760,983 @ $0.29 · Other (J): 2,000,000 (derivative) @ $0.50EDGAR
2023-12-044LEE WILLIS C — COO, DirectorPurchase (P): 1,365 @ $0.21 · Purchase (P): 900 @ $0.15 · Purchase (P): 132 @ $0.12 · Purchase (P): 1,470 @ $0.12 · Purchase (P): 4,325 @ $0.12 · Purchase (P): 7,417 @ $0.12EDGAR
2023-06-024LEE WILLIS C — COO, DirectorPurchase (P): 750 @ $0.28 · Purchase (P): 28,700 @ $0.29EDGAR
2023-01-204ZEN Wei Peu — DirectorPurchase (P): 2,000,000 (derivative) @ $0.50EDGAR
2023-01-194/ALEE WILLIS C — COO, DirectorGrant/award (A): 500,000 (derivative) @ $4.50EDGAR
2023-01-174Lim Seah H. — DirectorGrant/award (A): 100,000 (derivative) @ $4.50EDGAR
2023-01-174Stark Charles William — SVP, Clinical DevelopmentGrant/award (A): 100,000 (derivative) @ $4.50EDGAR
2023-01-174Sekulich George — CIO & SVPGrant/award (A): 100,000 (derivative) @ $4.50EDGAR
2023-01-174ZEN Wei Peu — DirectorGrant/award (A): 100,000 (derivative) @ $4.50EDGAR
2023-01-174Zwicker Ian Harvey — DirectorGrant/award (A): 100,000 (derivative) @ $4.50EDGAR
2023-01-174NAGASAKI YASUSHI — CFOGrant/award (A): 150,000 (derivative) @ $4.50EDGAR
2023-01-174LEE WILLIS C — COO, DirectorGrant/award (A): 750,000 (derivative) @ $4.50EDGAR
2023-01-174Niihara Yutaka — Chairman and CEO, Director, 10% ownerGrant/award (A): 7,500,000 (derivative) @ $4.50EDGAR
2022-12-014Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 2,500 @ $0.45 · Purchase (P): 7,500 @ $0.45 · Purchase (P): 5,000 @ $0.35 · Purchase (P): 14,700 @ $0.38 · Purchase (P): 22,900 @ $0.41EDGAR
2022-11-034Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 7,500 @ $0.45 · Purchase (P): 5,000 @ $0.43 · Purchase (P): 15,000 @ $0.43EDGAR
2022-10-314Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 7,500 @ $0.22 · Purchase (P): 20,000 @ $0.26 · Purchase (P): 11,900 @ $0.27 · Purchase (P): 22,500 @ $0.27 · Purchase (P): 7,500 @ $0.42EDGAR
2022-10-244Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 25,000 @ $0.16 · Purchase (P): 30,000 @ $0.18 · Purchase (P): 10,000 @ $0.19EDGAR
2022-10-194Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 15,000 @ $0.20 · Purchase (P): 30,000 @ $0.19EDGAR
2022-10-174Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 62,500 @ $0.18 · Purchase (P): 35,000 @ $0.17EDGAR
2022-10-134Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 5,000 @ $0.09 · Purchase (P): 160,000 @ $0.08EDGAR
2022-10-124Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 6,000 @ $0.20 · Purchase (P): 5,000 @ $0.20 · Purchase (P): 10,000 @ $0.20 · Purchase (P): 5,000 @ $0.16 · Purchase (P): 10,000 @ $0.15 · Purchase (P): 5,000 @ $0.15 · +3 moreEDGAR
2022-07-254LEE WILLIS C — COO, DirectorPurchase (P): 3,200 @ $0.39EDGAR
2022-06-034LEE WILLIS C — Director & COO, DirectorPurchase (P): 2,500 @ $0.37 · Purchase (P): 2,500 @ $0.40EDGAR
2022-06-024Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 5,000 @ $0.49 · Purchase (P): 2,000 @ $0.50EDGAR
2022-05-194Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 6,000 @ $0.60 · Purchase (P): 10,000 @ $0.34 · Purchase (P): 7,351 @ $0.35EDGAR
2022-04-124LEE WILLIS C — Director & COO, DirectorPurchase (P): 3,200 @ $0.98 · Purchase (P): 1,400 @ $0.95 · Purchase (P): 1,600 @ $0.76 · Purchase (P): 8,900 @ $0.88EDGAR
2022-03-024Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 53,800 @ $1.49EDGAR
2022-02-284LEE WILLIS C — Vice Chairman & COO, DirectorPurchase (P): 500 @ $1.42 · Purchase (P): 5,900 @ $1.44 · Purchase (P): 7,200 @ $1.51 · Purchase (P): 6,600 @ $1.50 · Purchase (P): 900 @ $1.65EDGAR
2022-02-284Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 11,000 @ $1.43 · Purchase (P): 5,500 @ $1.41EDGAR
2022-02-234Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 1,500 @ $1.43 · Purchase (P): 17,800 @ $1.44EDGAR
2022-02-184Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 1,000 @ $1.47 · Purchase (P): 6,500 @ $1.43EDGAR
2022-02-164Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 6,000 @ $1.45 · Purchase (P): 6,000 @ $1.45EDGAR
2022-02-114Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 23,500 @ $1.45 · Purchase (P): 3,000 @ $1.45 · Purchase (P): 4,000 @ $1.49EDGAR
2022-02-094Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 5,250 @ $1.47 · Purchase (P): 3,250 @ $1.49EDGAR
2022-02-074Niihara Yutaka — Chairman and CEO, Director, 10% ownerPurchase (P): 6,250 @ $1.40 · Purchase (P): 7,000 @ $1.43EDGAR
2022-01-054Lui Alfred Fu Kong — DirectorPurchase (P): 10,000 @ $1.58EDGAR
2022-01-054LEE WILLIS C — Vice Chairman & COO, DirectorPurchase (P): 500 @ $1.54 · Purchase (P): 200 @ $1.74 · Purchase (P): 500 @ $1.52 · Purchase (P): 500 @ $1.50EDGAR

Recent 8-K events — Emmaus Life Sciences, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-198-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-158-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-178-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-148-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-318-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-048-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-318-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-228-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-198-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=EMMA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs